Cargando...
Discrepancies in Composition and Biological Effects of Different Formulations of Chondroitin Sulfate
Osteoarthritis is a common, progressive joint disease, and treatments generally aim for symptomatic improvement. However, SYmptomatic Slow-Acting Drugs in Osteoarthritis (SYSADOAs) not only reduce joint pain, but slow structural disease progression. One such agent is chondroitin sulfate—a complex, h...
Gardado en:
| Publicado en: | Molecules |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6272499/ https://ncbi.nlm.nih.gov/pubmed/25756648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules20034277 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|